BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32471472)

  • 1. Radiation therapy is an important factor to improve survival in pediatric patients with head and neck rhabdomyosarcoma by enhancing local control: a historical cohort study from a single center.
    Wen Y; Huang D; Zhang W; Zhang Y; Hu H; Li J
    BMC Pediatr; 2020 May; 20(1):265. PubMed ID: 32471472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical characteristics and prognosis analysis of 46 cases of newly diagnosed localized head and neck rhabdomyosarcoma].
    Zhang CG; Zhou SY; Liu P; Qin Y; Yang JL; He XH; Shi YK
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(34):2722-2726. PubMed ID: 30220168
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical features and prognostic analysis of testicular relapse in pediatric acute lymphoblastic leukemia].
    Wang N; Gao YY; Qi BQ; Ruan M; Lyu H; Zhang XY; Zhang RR; Liu TF; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Zhu XF; Chen XJ
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):262-267. PubMed ID: 38378289
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
    Tsuchihashi K; Ito M; Arita S; Kusaba H; Kusano W; Matsumura T; Kitazono T; Ueno S; Taguchi R; Yoshihiro T; Doi Y; Arimizu K; Ohmura H; Kajitani T; Nio K; Nakano M; Oshima K; Tamura S; Shirakawa T; Shimokawa H; Uchino K; Hanamura F; Okumura Y; Komoda M; Isobe T; Ariyama H; Esaki T; Hashimoto K; Komune N; Matsuo M; Matsumoto K; Asai K; Yoshitake T; Yamamoto H; Oda Y; Akashi K; Baba E
    BMC Cancer; 2023 Oct; 23(1):1046. PubMed ID: 37904096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
    Abd El-Aal HH; Habib EE; Mishrif MM
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survival.
    Zhao D; Zhou F; Liu W; Huang Z; Xu X; Zheng B; Liu C; Bai C; Liu J; Sun Y; Wang W; Xiao S
    BMC Cancer; 2024 Mar; 24(1):340. PubMed ID: 38486204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study.
    Glosli H; Bisogno G; Kelsey A; Chisholm JC; Gaze M; Kolb F; McHugh K; Shipley J; Gallego S; Merks JHM; Smeele LE; Mandeville H; Ferrari A; Minard-Colin V; Corradini N; Jenney M; Zanetti I; De Salvo GL; Orbach D;
    Eur J Cancer; 2021 Jul; 151():84-93. PubMed ID: 33971448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical manifestations of Langerhans cell histiocytosis with multisystem involvement in 53 children].
    Tang JJ; Xu XJ; Wang YC; Bai ST; Wang L; Ni XL; Liu YF
    Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):37-41. PubMed ID: 33397002
    [No Abstract]   [Full Text] [Related]  

  • 10. The Impact of Radiation Therapy in Children and Adolescents With Metastatic Rhabdomyosarcoma.
    Cameron AL; Elze MC; Casanova M; Geoerger B; Gaze MN; Minard-Colin V; McHugh K; van Rijn RR; Kelsey A; Martelli H; Mandeville H; Bisogno G; Lowis S; Ronghe M; Orbach D; Guizani C; Fürst-Recktenwald S; Chisholm JC; Merks JHM;
    Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):968-978. PubMed ID: 34217789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.
    Merks JH; De Salvo GL; Bergeron C; Bisogno G; De Paoli A; Ferrari A; Rey A; Oberlin O; Stevens MC; Kelsey A; Michalski J; Hawkins DS; Anderson JR
    Ann Oncol; 2014 Jan; 25(1):231-6. PubMed ID: 24356633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and prognostic analysis of 458 children with high-risk neuroblastoma in a single center].
    Su Y; Ma XL; Wang HM; Qin H; Qin MQ; Zhang FQ; Jin M; Zhang DW; Chen CH; Zeng Q; He LJ; Ni X
    Zhonghua Er Ke Za Zhi; 2020 Oct; 58(10):796-801. PubMed ID: 32987457
    [No Abstract]   [Full Text] [Related]  

  • 13. [Retrospective study of 70 cases with the head and neck non-parameningeal rhabdomyosarcoma].
    Zhang G; Wang SC; Su Y; Liu ZK; Yu GX; Zhang J; Mei L; Sun N; Li YZ; Zhang XX; Liu QY; Liu ZY; Li XD; Ni X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Feb; 59(2):133-139. PubMed ID: 38369791
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy.
    Doyen J; Jazmati D; Geismar D; Frisch S; Schleithoff SS; Vermeren X; Scheer M; Blase C; Tippelt S; Timmermann B
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1043-1054. PubMed ID: 31419513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse after nonmetastatic rhabdomyosarcoma: Salvage rates and prognostic variables.
    Bergamaschi L; Chiaravalli S; Livellara V; Sironi G; Puma N; Nigro O; Gattuso G; Luksch R; Terenziani M; Spreafico F; Meazza C; Podda M; Biassoni V; Schiavello E; Hovsepyan S; Morosi C; Vennarini S; Massimino M; Casanova M; Ferrari A
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30050. PubMed ID: 36215173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
    J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of 26 children with postoperative residual or recurrent fibrosarcoma].
    Tang JJ; Pan C; Gao YJ; Han YL; Hu WT; Zhang J; Zhou M; Tang JY
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):668-673. PubMed ID: 32842388
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of clinical outcome in pediatric oligodendroglioma: meta-analysis of individual patient data and multiple imputation.
    Wang KY; Vankov ER; Lin DDM
    J Neurosurg Pediatr; 2018 Feb; 21(2):153-163. PubMed ID: 29192869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A long-term follow-up report of pediatric relapsed Wilms tumor after retreatment].
    Wang TY; Pan C; Gao YJ; Hu WT; Ye QD; Zhou M; Tang JY
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):743-747. PubMed ID: 29050111
    [No Abstract]   [Full Text] [Related]  

  • 20. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
    Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC
    Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.